These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 18682242)

  • 1. Evi-1 is a critical regulator for hematopoietic stem cells and transformed leukemic cells.
    Goyama S; Yamamoto G; Shimabe M; Sato T; Ichikawa M; Ogawa S; Chiba S; Kurokawa M
    Cell Stem Cell; 2008 Aug; 3(2):207-20. PubMed ID: 18682242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survivin modulates genes with divergent molecular functions and regulates proliferation of hematopoietic stem cells through Evi-1.
    Fukuda S; Hoggatt J; Singh P; Abe M; Speth JM; Hu P; Conway EM; Nucifora G; Yamaguchi S; Pelus LM
    Leukemia; 2015 Feb; 29(2):433-40. PubMed ID: 24903482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of Runx1/AML1 and Evi-1 in the regulation of hematopoietic stem cells.
    Kumano K; Kurokawa M
    J Cell Physiol; 2010 Feb; 222(2):282-5. PubMed ID: 19847803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pbx1 is a downstream target of Evi-1 in hematopoietic stem/progenitors and leukemic cells.
    Shimabe M; Goyama S; Watanabe-Okochi N; Yoshimi A; Ichikawa M; Imai Y; Kurokawa M
    Oncogene; 2009 Dec; 28(49):4364-74. PubMed ID: 19767769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evi-1 as a critical regulator of leukemic cells.
    Goyama S; Kurokawa M
    Int J Hematol; 2010 Jun; 91(5):753-7. PubMed ID: 20532840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evi-1 is a transcriptional target of mixed-lineage leukemia oncoproteins in hematopoietic stem cells.
    Arai S; Yoshimi A; Shimabe M; Ichikawa M; Nakagawa M; Imai Y; Goyama S; Kurokawa M
    Blood; 2011 Jun; 117(23):6304-14. PubMed ID: 21190993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic transcription factor Evi1 regulates hematopoietic stem cell proliferation through GATA-2 expression.
    Yuasa H; Oike Y; Iwama A; Nishikata I; Sugiyama D; Perkins A; Mucenski ML; Suda T; Morishita K
    EMBO J; 2005 Jun; 24(11):1976-87. PubMed ID: 15889140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AML1-Evi-1 specifically transforms hematopoietic stem cells through fusion of the entire Evi-1 sequence to AML1.
    Takeshita M; Ichikawa M; Nitta E; Goyama S; Asai T; Ogawa S; Chiba S; Kurokawa M
    Leukemia; 2008 Jun; 22(6):1241-9. PubMed ID: 18337762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of EVI-1 in normal hematopoiesis and myeloid malignancies (Review).
    Yuan X; Wang X; Bi K; Jiang G
    Int J Oncol; 2015 Dec; 47(6):2028-36. PubMed ID: 26496831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RUNX1-Evi-1 fusion gene inhibited differentiation and apoptosis in myelopoiesis: an in vivo study.
    Shen L; Zhu J; Chen F; Lin W; Cai J; Zhong J; Zhong H
    BMC Cancer; 2015 Dec; 15():970. PubMed ID: 26674644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis.
    Ichikawa M; Asai T; Saito T; Seo S; Yamazaki I; Yamagata T; Mitani K; Chiba S; Ogawa S; Kurokawa M; Hirai H
    Nat Med; 2004 Mar; 10(3):299-304. PubMed ID: 14966519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription factor Gfi1 regulates self-renewal and engraftment of hematopoietic stem cells.
    Zeng H; Yücel R; Kosan C; Klein-Hitpass L; Möröy T
    EMBO J; 2004 Oct; 23(20):4116-25. PubMed ID: 15385956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EVI-1 modulates leukemogenic potential and apoptosis sensitivity in human acute lymphoblastic leukemia.
    Konantz M; André MC; Ebinger M; Grauer M; Wang H; Grzywna S; Rothfuss OC; Lehle S; Kustikova OS; Salih HR; Handgretinger R; Fend F; Baum C; Kanz L; Quintanilla-Martinez L; Schulze-Osthoff K; Essmann F; Lengerke C
    Leukemia; 2013 Jan; 27(1):56-65. PubMed ID: 22828445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenetic significance of ecotropic viral integration site-1 in hematological malignancies.
    Goyama S; Kurokawa M
    Cancer Sci; 2009 Jun; 100(6):990-5. PubMed ID: 19385966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms of leukemogenesis by AML1/EVI-1.
    Mitani K
    Oncogene; 2004 May; 23(24):4263-9. PubMed ID: 15156182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional differences between two Tie2 ligands, angiopoietin-1 and -2, in regulation of adult bone marrow hematopoietic stem cells.
    Gomei Y; Nakamura Y; Yoshihara H; Hosokawa K; Iwasaki H; Suda T; Arai F
    Exp Hematol; 2010 Feb; 38(2):82-9. PubMed ID: 19945502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
    Liebermann DA; Hoffman B
    Stem Cells; 1994 Jul; 12(4):352-69. PubMed ID: 7951003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lhx2 expression in hematopoietic progenitor/stem cells in vivo causes a chronic myeloproliferative disorder and altered globin expression.
    Richter K; Pinto do O P; Hägglund AC; Wahlin A; Carlsson L
    Haematologica; 2003 Dec; 88(12):1336-47. PubMed ID: 14687986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YBX1 expression and function in early hematopoiesis and leukemic cells.
    Bhullar J; Sollars VE
    Immunogenetics; 2011 Jun; 63(6):337-50. PubMed ID: 21369783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced Erg Dosage Impairs Survival of Hematopoietic Stem and Progenitor Cells.
    Xie Y; Koch ML; Zhang X; Hamblen MJ; Godinho FJ; Fujiwara Y; Xie H; Klusmann JH; Orkin SH; Li Z
    Stem Cells; 2017 Jul; 35(7):1773-1785. PubMed ID: 28436588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.